Peter Diamandis Launches NeoGenesis Capital to Back Colossal's Programmable Biology Spinouts
PeterDiamandis · x · 2026-10-15
Peter Diamandis and Yianni Psaltis are launching NeoGenesis Capital. Diamandis was an early investor in Colossal Biosciences five years ago; the fund will invest in Colossal and the spinout companies built on its superintelligence-x-synthetic-biology platform across food, environment, and more.
More from Venture
- Former Kleiner Perkins partner Bucky Moore strikes out to raise his own fund — nmasc_ · 2026-10-15
- Comparison pages are among the highest-ROI plays for winning AI search — jia_seed · 2026-10-15
- Investor: AI-generated cold emails and pitch decks get auto-deleted — dauber · 2026-10-15
- Why should interest rate expectations move AI stocks at all? — inductionheads · 2026-10-15
- Perplexity Computer Adds Polymarket Integration Covering 250,000+ Prediction Markets — SuhailKakar · 2026-10-15
- Two successful RAG audits, zero paying clients: technical interest isn't buying intent — SeaAstronomer9044 · 2026-10-15